Greenwich LifeSciences (GLSI) Change in Account Payables (2019 - 2025)
Greenwich LifeSciences (GLSI) posted Change in Account Payables of $2.1 million for Q4 2025, up 1240.89% on a QoQ basis from -$187590.0 in Q3 2025, and up 5.52% year-over-year from $2.0 million in Q4 2024.
Greenwich LifeSciences (GLSI) Change in Account Payables (2019 - 2025) Analysis & Trends
Greenwich LifeSciences' Change in Account Payables history runs 6 years deep, the most recent figure standing at $2.1 million for Q4 2025.
- Quarterly Change in Account Payables rose 5.52% year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.1 million (down 18.66% YoY) and the FY2025 annual result came in at $2.1 million, down 18.66% from the prior year.
- Change in Account Payables was $2.1 million for Q4 2025 at Greenwich LifeSciences, up from -$187590.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.1 million in Q4 2025 and bottomed at -$560472.0 in Q3 2024.
- A 4-year average of $311330.3 and a median of -$69561.0 in 2023 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 7880.28% in 2024, while the deepest fall reached 705.73% in 2024.
- Greenwich LifeSciences' Change in Account Payables stood at -$75000.0 in 2021, then soared by 133.89% to $25415.0 in 2023, then surged by 7880.28% to $2.0 million in 2024, then gained by 5.52% to $2.1 million in 2025.
- Business Quant data shows GLSI's Change in Account Payables at $2.1 million in Q4 2025, -$187590.0 in Q3 2025, and $248595.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | 2.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.14 Mn |
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | -187,590.00 |
| Sep 30, 2025 | -187,590.00 |
| Jun 30, 2025 | 248,595.00 |
| Jun 30, 2025 | 248,595.00 |
| Mar 31, 2025 | -129,655.00 |
| Mar 31, 2025 | -129,655.00 |
| Dec 31, 2024 | 2.03 Mn |
| Dec 31, 2024 | 2.03 Mn |
| Sep 30, 2024 | -560,472.00 |
| Sep 30, 2024 | -560,472.00 |
| Jun 30, 2024 | 988,649.00 |
| Jun 30, 2024 | 988,649.00 |
| Mar 31, 2024 | 90,265.00 |
| Mar 31, 2024 | 90,265.00 |
| Dec 31, 2023 | 25,415.00 |
| Dec 31, 2023 | 25,415.00 |
| Sep 30, 2023 | -69,561.00 |
| Sep 30, 2023 | -69,561.00 |